Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex

Background. Multiple sclerosis (MS) is an autoimmune inflammatory disease of central nervous system (CNS). MS affects quality of Life (QOL) due to physical disability and other associated problems. Disease-modifying agents like interferon beta (IFNB) have been widely utilized in this patient populat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Abolfazli, R., Hosseini, A., Gholami, Kh., Javadi, M. R., Torkamandi, H., Emami, S.
Formato: Artigo
Idioma:Inglês
Publicado em: International Scholarly Research Network 2012
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3423918/
https://ncbi.nlm.nih.gov/pubmed/22928117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5402/2012/786526
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados